<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04944927</url>
  </required_header>
  <id_info>
    <org_study_id>69HCL21_0493</org_study_id>
    <nct_id>NCT04944927</nct_id>
  </id_info>
  <brief_title>HEmiplegia Arrhythmia Retrospective Trial</brief_title>
  <acronym>HEART</acronym>
  <official_title>Role of Alternating Hemiplegia of Childhood Genotype in Cardiac Repolarization. HEART: HEmiplegia Arrhythmia Retrospective Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hospices Civils de Lyon</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Hospices Civils de Lyon</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Alternating Hemiplegia of Childhood (AHC) is a rare and severe disease that is in need of&#xD;
      effective, and hopefully even curative, therapies. Afflicted patients suffer from severe&#xD;
      paralyzing crises, often excruciatingly painful muscle spasms, severe often life threatening&#xD;
      epileptic seizures, frequently severe developmental and psychiatric/psychological&#xD;
      disabilities and other comorbidities, such as cardiac disturbances. Recent data indicate that&#xD;
      AHC genotype is in relation to cardiac repolarization troubles and to cardiac arrhythmias.&#xD;
      The primary hypothesis to explore is that there is an association between genotype and&#xD;
      cardiac phenotype in AHC.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">April 29, 2021</start_date>
  <completion_date type="Anticipated">June 2022</completion_date>
  <primary_completion_date type="Anticipated">December 2021</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Measurement of QTc interval and all relevant cardiac repolarization measurements</measure>
    <time_frame>at inclusion</time_frame>
    <description>Outcome measure: QTc interval and cardiac repolarization measurement in milliseconds.</description>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">20</enrollment>
  <condition>Alternating Hemiplegia of Childhood</condition>
  <arm_group>
    <arm_group_label>Patients with Alternating Hemiplegia of Childhood</arm_group_label>
    <description>Patients that meet the clinical diagnostic criteria (Aicardi et al, 1995) for typical alternating hemiplegia with or without identified mutations in ATP1A3.&#xD;
At least one prolonged ECG study available is required.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Recording of clinical parameters and electrocardiogram parameters</intervention_name>
    <description>Retrospective recording of demographic information (age, sex, age at diagnosis), genetic information, cardiological information, pharmacological treatments, electrocardiogram data. All above data will be deidentified.</description>
    <arm_group_label>Patients with Alternating Hemiplegia of Childhood</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients with Alternating Hemiplegia of Childhood&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Patients that meet the clinical diagnostic criteria (Aicardi et al, 1995) for typical&#xD;
             alternating hemiplegia with or without identified mutations in ATP1A3.&#xD;
&#xD;
          -  At least one ECG study is required.&#xD;
&#xD;
          -  Patients ages yearand more&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Informed consent or assent not obtainable&#xD;
&#xD;
          -  ATP1A3 testing not performed&#xD;
&#xD;
          -  No ECG studies are available&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>12 Months</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Eleni PANAGIOTAKAKI, MD</last_name>
    <phone>4 27 85 60 60</phone>
    <phone_ext>+33</phone_ext>
    <email>eleni.panagiotakaki@chu-lyon.fr</email>
  </overall_contact>
  <location>
    <facility>
      <name>Department of Clinical Epileptology, Sleep Disorders and Functional Neurology in Children, Hôpital Femme Mère Enfant, University Hospitals of Lyon (Hospices Civils de Lyon)</name>
      <address>
        <city>Bron</city>
        <zip>69677</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>May 2021</verification_date>
  <study_first_submitted>June 2, 2021</study_first_submitted>
  <study_first_submitted_qc>June 21, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">June 30, 2021</study_first_posted>
  <last_update_submitted>June 21, 2021</last_update_submitted>
  <last_update_submitted_qc>June 21, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">June 30, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>QTc</keyword>
  <keyword>Cardiac repolarization and arrhythmia</keyword>
  <keyword>ECG</keyword>
  <keyword>Alternating Hemiplegia</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hemiplegia</mesh_term>
    <mesh_term>Arrhythmias, Cardiac</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

